Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.
Saved in:
| Title: | Combination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial. |
|---|---|
| Authors: | Boeder SC; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA., Thomas RL; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA., Le Roux MJ; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA., Giovannetti ER; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA., Gregory JM; Ian M. Burr Division of Pediatric Endocrinology and Diabetes, Vanderbilt University School of Medicine, Nashville, TN., Pettus JH; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Diego, La Jolla, CA. |
| Source: | Diabetes care [Diabetes Care] 2025 Jan 01; Vol. 48 (1), pp. 52-60. |
| Publication Type: | Journal Article; Randomized Controlled Trial |
| Journal Info: | Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print Cited Medium: Internet ISSN: 1935-5548 (Electronic) Linking ISSN: 01495992 NLM ISO Abbreviation: Diabetes Care Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1935-5548 |
|---|---|
| DOI: | 10.2337/dc24-0212 |
